Emergent BioSolutions of Gaithersburg will lay off 154 workers, and shutter its Rockville manufacturing facility, the company announced as part of a restructuring. It will also eliminate some vacant positions, in an attempt to save $80 million. The biotech firm will scale back its goals to focus on its core businesses: medical countermeasures and NARCAN Nasal Spray.
"Decisions like these are never easy as they have real impact on many of our dedicated colleagues," Emergent CEO Joe Papa said in a statement. "We are committed to providing resources to those affected as they transition to new opportunities." Emergent will concentrate its operations at sites in Winnipeg, Canada, and Lansing, Michigan.
No comments:
Post a Comment